# Regard

> Regard is a New York-based healthcare AI company that builds a clinical insights platform acting as an AI co-pilot for physicians. It reviews the full electronic health record - not just the sliver of chart data doctors typically read - to proactively surface likely diagnoses and draft near-complete clinical documentation before a patient is seen. Used by clinicians across 150+ hospitals, Regard aims to reduce missed diagnoses, ease documentation burden, and recover otherwise-lost hospital revenue.

- **Founded:** 2017
- **Headquarters:** New York, New York, United States
- **Founders:** Eli Ben-Joseph (Co-Founder & CEO), Nate Wilson (Co-Founder), Thomas Moulia (Co-Founder)
- **Team size:** ~95 employees
- **Products:** Clinical Notes, Mid-Revenue Cycle, HCC Capture, Screening, Proactive Documentation Platform
- **Notable:** Raised $61M Series B in July 2024 at a $350M valuation, led by Oak HC/FT., Surfaced over 10 million diagnoses accepted by clinicians (up from 3M+ at Series B)., Unlocked more than $50 million in earned revenue for health-system customers.

## Products & services

- **Clinical Notes** — AI-powered diagnostic support that reviews the full EHR and generates near-complete clinical notes with recommended diagnoses before the physician sees the patient.
- **Mid-Revenue Cycle** — Captures missed or under-documented diagnoses before they turn into clinical documentation queries or payer denials.
- **HCC Capture** — Identifies hierarchical condition codes to support accurate risk adjustment and appropriate reimbursement.
- **Screening** — Surfaces patients eligible for high-value procedures and interventions from the clinical data.
- **Proactive Documentation Platform** — Combines all data in the patient chart with data from patient-physician conversations to surface diagnostic insights and draft a note before the encounter.

## Achievements

- Raised $61M Series B in July 2024 at a $350M valuation, led by Oak HC/FT.
- Surfaced over 10 million diagnoses accepted by clinicians (up from 3M+ at Series B).
- Unlocked more than $50 million in earned revenue for health-system customers.
- Deployed across 150+ hospitals in 15+ states.
- Grew revenue approximately 4.5x in 2023.
- CEO Eli Ben-Joseph named to Crain's New York Notable Leaders in Health Care Technology 2025 and Forbes Technology Council.
- Launched the first platform to combine chart data with patient-physician conversations for diagnosis recommendations (2025).

## Latest updates

- **2025-07** — Launched a proactive documentation platform - the first to combine chart data with patient-physician conversations to recommend diagnoses and draft notes before an encounter.
- **2025-01** — Reached 10 million diagnoses surfaced and accepted by clinicians; expanded platform to new specialties toward use across all admitted patients.
- **2024-07** — Closed $61M Series B led by Oak HC/FT at a $350M valuation to expand the clinical insights platform and invest in LLM research.

## Links

- Website: https://regard.com
- LinkedIn: https://www.linkedin.com/company/regard-technologies/

---

Profile page: https://yespress.io/regard
Published by YesPress — https://yespress.io
Last updated: 2026-07-18